Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction
1 other identifier
interventional
30
1 country
1
Brief Summary
It has been shown, that subjects susceptible to high altitude pulmonary edema (HAPE)are characterized by an abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia. This abnormal rise of pulmonary artery pressure has also been observed in about 10 % of otherwise healthy subjects without prior altitude exposure. The aim of the study is to investigate the susceptibility to HAPE in unacclimatized subjects with abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia after rapid ascent to high altitude (4559 m).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 15, 2007
CompletedFirst Posted
Study publicly available on registry
November 16, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedSeptember 6, 2013
November 1, 2007
3.5 years
November 15, 2007
September 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of HAPE after rapid ascent to 4559 m
during the 48 h stay at altitude
Secondary Outcomes (2)
Time course of pulmonary artery pressure
during the 48 h stay at altitude
Assessment of right ventricular function by echocardiography
during the 48 h stay at altitude
Study Arms (1)
1
EXPERIMENTALhigh altitude exposure without prior acclimatization
Interventions
Eligibility Criteria
You may qualify if:
- abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia
- ability to climb Margherita Hut
You may not qualify if:
- Birth at or above 1500 m altitude
- any cardiovascular or pulmonary disease
- Infection disease
- Intake of drugs, in particular Acetazolamide, Nifedipine, corticosteroids or PDE-5-inhibitors.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sports Medicine, University Hospital
Heidelberg, 69120, Germany
Related Publications (1)
Dehnert C, Mereles D, Greiner S, Albers D, Scheurlen F, Zugel S, Bohm T, Vock P, Maggiorini M, Grunig E, Bartsch P. Exaggerated hypoxic pulmonary vasoconstriction without susceptibility to high altitude pulmonary edema. High Alt Med Biol. 2015 Mar;16(1):11-7. doi: 10.1089/ham.2014.1117.
PMID: 25803140DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Dehnert, MD
University Hospital Heidelberg
- PRINCIPAL INVESTIGATOR
Ekkehard Grünig, MD
University Hospital Heidelberg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 15, 2007
First Posted
November 16, 2007
Study Start
June 1, 2007
Primary Completion
December 1, 2010
Study Completion
July 1, 2011
Last Updated
September 6, 2013
Record last verified: 2007-11